300110SZSE

Hua Ren Pharmaceutical Co., Ltd.

华仁药业

300110

Shenzhen Stock Exchange

63 announcements tracked· Last: September 22, 2026

Key Financials

As of 2026-09-19T00:00:00.000+00:00
Revenue¥605.0M
Net Profit¥28.5M
ROE3.29%
Debt Ratio65.83%
Monetary Funds¥212.7M
Receivables¥455.9M
Goodwill¥207.9M
Total Shares1.18bn

Announcements

63 totalCSV

Notes & Comments

Sign in to leave a comment or private note.

No notes or comments yet.